Navelbine® is a drug used as a chemotherapy treatment for mesothelioma. A brand name, prescription only drug, Navelbine® is one of the most recently developed treatments for mesothelioma — the cancer that is most often caused by asbestos exposure.
Generic Name: Vinorelbine Tartrate
The generic name for Navelbine is vinorelbine (vin NO rell been), a drug that was discovered and patented in Europe in 1978. Over a million people in some 80 countries have been treated with vinorelbine since it was launched as a treatment for non-small cell lung cancer (NSCLC). It’s also used to treat breast cancer.
Navelbine Has a Higher Response Rate
Navelbine can be administered intravenously or in capsule form to be taken orally. In clinical trials, about 25 percent of the mesothelioma patients who were given Navelbine showed a positive response to it. Although 25 percent may not seem like a great result, it’s about 5 percent higher than the success rate for most other chemotherapy drugs.
Navelbine (Vinorelbine) Side Effects
Another advantage of Navelbine is that it has much fewer side effects than many of the drugs used for chemotherapy. It does still have some side effects, though, including:
- flu-like symptoms
- lowered resistance to infection
- increased bleeding or bruising risk
How Navelbine (vinorelbine) Works
Navelbine blocks the growth of cancer (e.g., breast or lung cancer or mesothelioma cancer) by stopping the cancer cells from dividing and multiplying. It can also be used together with another chemotherapy drug. Navelbine is manufactured by a company based in France: Pierre Fabre Pharmaceuticals.
Learn More about Navelbine for Mesothelioma
If a mesothelioma diagnosis is suspected or confirmed for you or for a member of your family, you can find out more about this treatment for mesothelioma and your legal rights as a possible victim of asbestos poisoning. Contact us today to speak with an experienced asbestos attorney that represents people who have been harmed by toxic substances such as asbestos.